Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
17.56
0.00 (0.00%)
At close: Jul 2, 2026, 4:00 PM EDT
17.62
+0.06 (0.34%)
Pre-market: Jul 6, 2026, 4:34 AM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $2.45 billion as of July 2, 2026. Its market cap has increased by 147.26% in one year.
Market Cap
2.45B
Enterprise Value
2.02B
1-Year Change
147.26%
Ranking
Category
Stock Price
$17.56
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $2.45B, an increase of 223.90%. That is a compound annual growth rate of 12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.45B | 135.62% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.67B |
| Trevi Therapeutics | 2.55B |
| Nurix Therapeutics | 2.48B |
| AbCellera Biologics | 2.48B |
| Mineralys Therapeutics | 2.44B |
| Kodiak Sciences | 2.41B |
| Biohaven | 2.40B |
| Nektar Therapeutics | 2.40B |